Day: October 2, 2023
J & J Lung Cancer Therapy Succeeds in Study with AstraZeneca’s Drug, Tagrisso
A head-to-head matchup between Johnson & Johnson combination and AstraZeneca’s drug, Tagrisso as a first-line treatment for non-small cell lung cancer [...]